These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37042095)

  • 21. Metabolomic spectral libraries for data-independent SWATH liquid chromatography mass spectrometry acquisition.
    Bruderer T; Varesio E; Hidasi AO; Duchoslav E; Burton L; Bonner R; Hopfgartner G
    Anal Bioanal Chem; 2018 Mar; 410(7):1873-1884. PubMed ID: 29411086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolite discovery through global annotation of untargeted metabolomics data.
    Chen L; Lu W; Wang L; Xing X; Chen Z; Teng X; Zeng X; Muscarella AD; Shen Y; Cowan A; McReynolds MR; Kennedy BJ; Lato AM; Campagna SR; Singh M; Rabinowitz JD
    Nat Methods; 2021 Nov; 18(11):1377-1385. PubMed ID: 34711973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of altered urinary metabolomic profiles of invasive ductal carcinoma of breast using targeted and untargeted approaches.
    More TH; Taware R; Taunk K; Chanukuppa V; Naik V; Mane A; Rapole S
    Metabolomics; 2018 Aug; 14(8):107. PubMed ID: 30830381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prioritization of putative metabolite identifications in LC-MS/MS experiments using a computational pipeline.
    Zhou B; Xiao JF; Ressom HW
    Proteomics; 2013 Jan; 13(2):248-60. PubMed ID: 23307777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome.
    Xu W; Chen D; Wang N; Zhang T; Zhou R; Huan T; Lu Y; Su X; Xie Q; Li L; Li L
    Anal Chem; 2015 Jan; 87(2):829-36. PubMed ID: 25486321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting human urinary metabolome by LC-MS/MS: a review.
    Rodríguez-Morató J; Pozo ÓJ; Marcos J
    Bioanalysis; 2018 Apr; 10(7):489-516. PubMed ID: 29561651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced MS/MS coverage for metabolite identification in LC-MS-based untargeted metabolomics by target-directed data dependent acquisition with time-staggered precursor ion list.
    Wang Y; Feng R; Wang R; Yang F; Li P; Wan JB
    Anal Chim Acta; 2017 Nov; 992():67-75. PubMed ID: 29054151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic reaction network-based recursive metabolite annotation for untargeted metabolomics.
    Shen X; Wang R; Xiong X; Yin Y; Cai Y; Ma Z; Liu N; Zhu ZJ
    Nat Commun; 2019 Apr; 10(1):1516. PubMed ID: 30944337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An untargeted metabolomics strategy to measure differences in metabolite uptake and excretion by mammalian cell lines.
    Wright Muelas M; Roberts I; Mughal F; O'Hagan S; Day PJ; Kell DB
    Metabolomics; 2020 Oct; 16(10):107. PubMed ID: 33026554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolite annotation from knowns to unknowns through knowledge-guided multi-layer metabolic networking.
    Zhou Z; Luo M; Zhang H; Yin Y; Cai Y; Zhu ZJ
    Nat Commun; 2022 Nov; 13(1):6656. PubMed ID: 36333358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated LC-MS and GC-MS-Based Metabolomics Reveal the Effects of Plant Competition on the Rye Metabolome.
    Hazrati H; Kudsk P; Ding L; Uthe H; Fomsgaard IS
    J Agric Food Chem; 2022 Mar; 70(9):3056-3066. PubMed ID: 35227064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging.
    Xu J; Chen Y; Zhang R; He J; Song Y; Wang J; Wang H; Wang L; Zhan Q; Abliz Z
    Sci Rep; 2016 Oct; 6():35010. PubMed ID: 27725730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma metabolome analysis by integrated ionization rapid-resolution liquid chromatography/tandem mass spectrometry.
    Tian H; Bai J; An Z; Chen Y; Zhang R; He J; Bi X; Song Y; Abliz Z
    Rapid Commun Mass Spectrom; 2013 Sep; 27(18):2071-80. PubMed ID: 23943328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LC-MS-based metabolomics in the clinical laboratory.
    Becker S; Kortz L; Helmschrodt C; Thiery J; Ceglarek U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():68-75. PubMed ID: 22074957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advancing untargeted metabolomics using data-independent acquisition mass spectrometry technology.
    Wang R; Yin Y; Zhu ZJ
    Anal Bioanal Chem; 2019 Jul; 411(19):4349-4357. PubMed ID: 30847570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of artificial intelligence using convolutional neural networks in determining the invasion depth of esophageal squamous cell carcinoma.
    Tokai Y; Yoshio T; Aoyama K; Horie Y; Yoshimizu S; Horiuchi Y; Ishiyama A; Tsuchida T; Hirasawa T; Sakakibara Y; Yamada T; Yamaguchi S; Fujisaki J; Tada T
    Esophagus; 2020 Jul; 17(3):250-256. PubMed ID: 31980977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-sensitive liquid chromatography-tandem mass spectrometry-based chiral metabolic profiling focusing on amino acids and related metabolites.
    Nakano Y; Taniguchi M; Fukusaki E
    J Biosci Bioeng; 2019 Apr; 127(4):520-527. PubMed ID: 30563742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Untargeted LC-MS Metabolomics for the Analysis of Micro-scaled Extracellular Metabolites from Hepatocytes.
    Abdalkader R; Chaleckis R; Meister I; Zhang P; Wheelock CE; Kamei KI
    Anal Sci; 2021 Jul; 37(7):1049-1052. PubMed ID: 33342928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
    Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
    J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.